The End of COVID-19 PHE: Practical Implications for Clinical Labs
In this webinar, our expert speakers will share what the end of the COVID-19 PHE will mean for clinical labs and how they can best prepare.
Diagnostic Testing and Emerging Technologies
LAB COMPLIANCE ADVISOR
LAB INDUSTRY REPORT
NATIONAL LAB REPORTER
Author Information
In this webinar, our expert speakers will share what the end of the COVID-19 PHE will mean for clinical labs and how they can best prepare.
Get up to date on annual billing changes and critical developments currently facing laboratory medicine.
Get an overview of trending areas of enforcement and steps labs and pathology practices can consider to protect their businesses.
Learn how to comprehend the difficulties of revenue cycle management and practical technology-based solutions in this free webinar.
We’re inviting our readers to share their ideas for topics and presenters, both for future standalone webinars and our virtual events.
This digital event will help labs meet the various legal, compliance, business, and technology challenges of the industry, today and tomorrow.
Completing the Advance Beneficiary Notice of Noncoverage form can be extremely complex; this guide helps simplify the process.
Most healthcare-related enforcement actions from July and August involved urine drug tests and genetic testing.
Here’s the Advance Beneficiary Notice of Non-Coverage that you should present to patients who speak Spanish, starting August 31, 2022.
Here’s the Advance Beneficiary Notice of Non-Coverage that you should present to patients, starting August 31, 2022.